| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2011-01-31 09:21:52 |
| Versijas komentārs | |
| Teksts |
Olaine, January 31, 2011
According to preliminary figures, sales of Olainfarm
exceed the forecast.
According to preliminary figures sales of a/s „Olainfarm”
last year were 25.2 million lats (35.85 milion Euro), which
represents about 13% increase to the sales of 2009. Tentative
target of sales for 2011 is at least 28 million lats (39.84 million
euro), also this year company plans to invest in
modernization.
“Over the last two years we have made relatively small
investments into development of the company, therefore most likely
the profit of 2011 might be somewhat smaller than that of 2010, as
we plan the capital expenditures of about 3 million lats this
year. This is besides investments in new producs and markets,
as we do continuously invest there. We will invest 3 million
in modernization and reconstruction of production units and
laboratories, we also plan to purchase some new equipment,” says
Valerijs Maligins, chairman of the Board of AS
“Olainfarm”.
Annual General Meeting of Shareholders of „Olainfarm” held on
April 29, 2010 approved the operating plan of the
company. According to it, the forecast sales of the Concern
for 2010 are 24.5 million lats (34.9 million Euro), but the net
profit is forecast at 2.7 million lats (3.8 million Euro).
Net profit of AS “Olainfarm” in 2009 was 2.36 million lats
(3.36 million euro), while sales were 22.4 million lats (32 millon
euro).
A/s Olainfarm is one of the
biggest pharmaceutical companies in Latvia with nearly 40 years of
experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 30 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia.
Information prepared by:
Salvis Lapins
Member of the Board
A/s „Olainfarm”
Tel: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: slapinsh@olainfarm.lv
|
| Pielikumi |
|